When Peter Thiel and Don Jr. Lose, It’s a Great Week for Humanity
By Virginia Heffernan,
The New Republic
| 05. 29. 2026
For us mere mortals, from the pope’s encyclical to the total failure of the Enhanced Games, it’s been a pretty good week.
Here and there, it’s been a good month for humanity—or “magnificas humanitas,” as Pope Leo XIV calls us poor featherless bipeds.
On May 25, the pope published his encyclical letter “on safeguarding the human person in the time of artificial intelligence.” It made a stern but loving case against AI fatalism, reminding humans of our intrinsic worth and cautioning against seeking transcendence in tech rather than grace.
But the human person got another boost in late May. It came from a less holy figure too: Peter Thiel, net worth $28 billion.
As the founder of omnipresent MAGA AI surveillance machine Palantirand longtime student of the Antichrist, Thiel didn’t mean to help out humanity. Benevolence is not his strong suit. He’s out to live forever and build a master race. But by failing to make the case for transhumanism with his much-hyped Enhanced Games, a pro-doping sports event, Thiel accidentally showcased what’s magnificent about humanity.
What makes Thiel’s Enhanced Games different from other competitions is that at his games, which wrapped May 24 in (where else?)...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...